Pharmaceutical industry to initiate major restructuring process.

Recent Hanmi's merger of Dongshin seems to gear up a major industrial restructuring movement that has remained latent since quite a long time, by either an aggressive approach, an acquisition and merger of other companies or a negative attitude such as a product transfer.

Hanmi said in the M&A with Dongshin that Dongshin will operate under the independent management system. However, consider...